Show simple item record

dc.contributor.authorCorbatón-Anchuelo, Arturo
dc.contributor.authorMartínez-Larrad, María Teresa
dc.contributor.authorDel Prado-González, Náyade
dc.contributor.authorFernández-Pérez, Cristina
dc.contributor.authorGabriel-Sanchez, Rafael 
dc.contributor.authorSerrano-Ríos, Manuel
dc.identifier.citationInt J Hypertens. 2018 Aug 14;2018:4851512.es_ES
dc.description.abstractThe prevalence and related factors of hypertensive subjects according to the resident area (rural versus urban) were investigated in two population-based studies from Spain. Medical questionnaires were administered and anthropometrics were measured, using standardized protocols. Hypertension was diagnosed in pharmacology treated subjects or those with blood pressure (BP) ≥140/90 mm Hg. Regarding BP control, it was defined as under control if BP was <140/90 or <140/85 mm Hg in type 2 diabetic subjects. Information on educational status, social class, smoking habit, and alcohol intake was obtained. 3,816 subjects (54.38 % women) were included. Prevalence of diagnosed hypertension was higher in women and showed no differences according to the living area (men: urban 21.88 versus rural 21.92 %, p = 0.986; women: urban 28.73 versus rural 30.01 %, p = 0.540). Women living in rural areas and men with secondary or tertiary education levels had a lower probability of being BP uncontrolled (OR (95 % CI): 0.501 (0.258-0.970)/p=0.040, 0.245 (0.092-0.654)/p=0.005, and 0.156 (0.044-0.549)/p=0.004, respectively). Urban young men (31-45 years) and medium aged women (46-60 years) were less BP controlled than their rural counterparts (41.30 versus 65.79 %/p=0.025 and 35.24 versus 53.27 %/p=0.002, respectively).es_ES
dc.description.sponsorshipThis work was supported by Grants FEDER 2FD 1997/2309 from the Fondo Europeo para el Desarrollo Regional, Red de Centros RCMN (C03/08), FIS 03/1618 from Instituto de Salud Carlos III-RETIC RD06/0015/0012, Madrid, Spain. The authors also acknowledge CIBER in Diabetes and Associated Metabolic Disorders (ISCIII, Ministerio de Ciencia e Innovación) and Madrid Autonomous Community (MOIR S2010/BMD-2423). Partial support also came from Educational Grants from Eli Lilly Lab, Spain, Bayer Pharmaceutical Co., Spain and Fundación Mutua Madrileña 2008, Spain. Members of the Segovia Insulin Resistance Study Group are acknowledged. The authors also acknowledge Milagros Pérez-Barba for dedicated and careful technical assistance.es_ES
dc.publisherSAGE, Hindawi Access to Research es_ES
dc.titlePrevalence, Treatment, and Associated Factors of Hypertension in Spain: A Comparative Study between Populationses_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.contributor.funderEuropean Regional Development Fund 
dc.contributor.funderInstituto de Salud Carlos III 
dc.contributor.funderComunidad de Madrid 
dc.identifier.journalInternational journal of hypertensiones_ES
dc.repisalud.centroISCIII::Escuela Nacional de Sanidades_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/FEDER 2FD 1997/2309es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/(C03/08), FIS 03/1618es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/MOIR S2010/BMD-2423es_ES
dc.rights.accessRightsopen accesses_ES

Files in this item

Acceso Abierto

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This item is licensed under a: Atribución 4.0 Internacional